Interstitial lung changes and persistent COVID-19 in a patient with follicular lymphoma: A case report

Makiko Yomota; Masaru Tanaka; Takayuki Kobayashi; Masatake Kitano; Saori Ikeda; Yusuke Kanemasa; Noriyo Yanagawa; Yukio Hosomi

doi:10.1002/rcr2.1298

Interstitial lung changes and persistent COVID-19 in a patient with follicular lymphoma: A case report

Respirol Case Rep. 2024 Feb 20;12(2):e01298. doi: 10.1002/rcr2.1298. eCollection 2024 Feb.

Authors

Makiko Yomota¹, Masaru Tanaka², Takayuki Kobayashi¹, Masatake Kitano¹, Saori Ikeda¹, Yusuke Kanemasa³, Noriyo Yanagawa⁴, Yukio Hosomi¹

Affiliations

¹ Department of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan.
² Department of Infectious Diseases Tokyo Metropolitan Komagome Hospital Tokyo Japan.
³ Department of Oncology Tokyo Metropolitan Komagome Hospital Tokyo Japan.
⁴ Department of Radiology Tokyo Metropolitan Komagome Hospital Tokyo Japan.

Abstract

We herein report a case of interstitial lung changes in a patient with prolonged coronavirus disease 2019 (COVID-19) with follicular lymphoma receiving rituximab and bendamustine who recovered after treatment with a combination therapy consisting of corticosteroids and immunosuppressive agents. There is currently no treatment strategy for prolonged pneumonitis following COVID-19, which can be life-threatening for immunocompromised patients. Thus, further investigation is warranted.

Keywords: COVID‐19; lymphoma; pneumonitis; tacrolimus.

Publication types

Case Reports